On Tuesday, Raytheon Company (NYSE:RTN)’s shares inclined 0.03% to $100.07.
Raytheon Company (RTN) declared net sales for the second quarter 2015 were $5.8 billion contrast to $5.7 billion in the second quarter 2014. Second quarter 2015 EPS from ongoing operations was $1.65 contrast to $1.59 in the second quarter 2014. Second quarter 2015 EPS from ongoing operations comprised of a favorable FAS/CAS Adjustment of $0.10 contrast to a favorable FAS/CAS Adjustment of $0.18 in the second quarter 2014. In addition, second quarter 2015 EPS from ongoing operations comprised of, as predictable, a $0.29 favorable impact from a tax settlement.
The Company had bookings of $7.6 billion in the second quarter 2015, resulting in a book-to-bill ratio of 1.30. In the second quarter 2014, bookings were $6.8 billion. Year-to-date 2015 bookings were $12.1 billion, resulting in a book-to-bill ratio of 1.08. Year-to-date 2014 bookings were $11.1 billion.
Raytheon Company develops integrated products, services, and solutions in the areas of sensing; effects; command, control, communications, and intelligence; mission support; and cyber and information security worldwide. It operates in four segments: Integrated Defense Systems (IDS); Intelligence, Information, and Services (IIS); Missile Systems (MS); and Space and Airborne Systems (SAS). The IDS segment provides integrated air and missile defense; radar solutions; naval combat and ship electronic systems; command, control, communications, computers, and intelligence solutions; and air traffic administration systems.
Becton, Dickinson and Co. (NYSE:BDX)’s shares dropped -4.03% to $134.89.
BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, declared recently an updated sustainability strategy and aims for 2020 as part of the release of its 2014 Sustainability Report.
The company’s new aims reflect a broader and more integrated agenda than in past years, recognizing four planned areas where BD will focus its efforts and reporting going forward:
- Innovation– health care safety, reach and cost
- Access– health care in resource-limited populations
- Efficiency– environmentally sound products and resilient operations
- Empowerment– positive workforce and community impacts
This is BD’s seventh annual Sustainability Report, highlighting progress achieved within the company’s past fiscal year between Oct. 1, 2013 and Sept. 30, 2014. The company plans to continue its long history of shared value creation, which addresses unmet societal needs through business models and initiatives that also contribute to commercial success.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The companys BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices.
At the end of Tuesday’s trade, Merge Healthcare Inc. (NASDAQ:MRGE)‘s shares surged 0.14% to $7.10.
Merge Healthcare Incorporated (MRGE), a leading provider of health information systems for medical imaging, interoperability, and communication, declared its financial and business results for the second quarter of 2015.
Financial Summary:
- GAAP net sales raised 22% to $65.6 million in the second quarter of 2015 contrast to $53.8 million in the second quarter of 2014;
- GAAP net income in the second quarter of 2015 was $2.0 million (or $0.01 per share) contrast to a loss of $4.0 million (or ($0.04) per share) in the second quarter of 2014 (which comprised of a $4.8 million debt refinancing charge);
- Adjusted net income raised 132% to $10.2 million (or $0.09 per share) in the second quarter of 2015 contrast to $4.4 million (or $0.05 per share) in the second quarter of 2014;
- Adjusted EBITDA was $16.7 million (or 25% of GAAP net sales) in the second quarter of 2015 contrast to $11.2 million (or 21% of GAAP net sales) in the second quarter of 2014; and
- Cash balances reduced to $20.6 million as of June 30, 2015, contrast to $23.9 million as of June 30, 2014, a decrease of 14%, primarily as a result of about $20 million of cash expended in 2015 to acquire D.R. Systems, Inc.
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide. It operates in two segments, Merge Healthcare and Merge DNA. The company provides iConnect Enterprise Archive and iConnect Access Enterprise Viewer, an interoperability and connectivity platform for imaging and diagnostic data access; iConnect Network to electronically manage in-bound medical imaging referrals and distribution of results to referring physicians; iConnect Cloud Archive, a cloud-based and multi-tenant image archive that provides disaster recovery/business continuity services; and iConnect Retinal Screening, a software solution for the screening of chronic visual diseases.
Teladoc Inc (NYSE:TDOC), ended its Tuesday ‘s trading session with 0.18% gain, and closed at $22.89.
CVS Health (CVS) recently declared that it is working with three proven telehealth companies – American Well, Doctor On Demand and Teladoc (TDOC) – to explore how direct-to-consumer telehealth providers, retail pharmacy and retail clinic providers can collaborate to improve patient care. This represents an expansion of CVS Health’s existing telehealth approach.
This declarement is part of CVS Health’s broader commitment to connected health, exploring new and effective ways that digital technology can improve the health care experience. “A key pillar of our strategy is forging the right partnerships within the industry,” said Brian Tilzer, senior vice president and chief digital officer, CVS Health. “We recognize that some of the best ideas are already being developed, so we’re committed to partnering with other companies to explore and expand on these ideas together.”
Teladoc, Inc. provides telehealth services via mobile devices, the Internet, video, and phone to clients and their customers in the United States. Its solution connects consumers with its physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis to dermatological conditions, anxiety, and smoking cessation. The company was founded in 2002 and is based in Dallas, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
